Viewing Study NCT02334527


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-06-07 @ 11:17 AM
Study NCT ID: NCT02334527
Status: TERMINATED
Last Update Posted: 2018-11-16
First Post: 2015-01-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-03-17
Start Date Type: ACTUAL
Primary Completion Date: 2016-12-02
Primary Completion Date Type: ACTUAL
Completion Date: 2017-09-28
Completion Date Type: ACTUAL
First Submit Date: 2015-01-06
First Submit QC Date: None
Study First Post Date: 2015-01-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-02-06
Results First Submit QC Date: None
Results First Post Date: 2018-04-24
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-11-15
Last Update Post Date: 2018-11-16
Last Update Post Date Type: ACTUAL